Outcome from surgical management of secretory pituitary adenomas in Christchurch, New Zealand

Internal Medicine Journal

Volumn 33, Issue 4, 2003, Pages 168-173

  Inder, W J ^a,b   Espiner, E A ^a   MacFarlane, M R ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Acromegaly; Cushing's disease; Trans sphenoidal surgery

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; ESMOLOL; GROWTH HORMONE; HYDROCORTISONE; THYROXINE;

ACROMEGALY; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CUSHING DISEASE; DIABETES INSIPIDUS; FEMALE; FOLLOW UP; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYPOPHYSIS ADENOMA; HYPOPITUITARISM; MALE; MEDICAL AUDIT; NEUROSURGERY; NEW ZEALAND; OUTCOMES RESEARCH; POSTOPERATIVE CARE; PRIORITY JOURNAL; REMISSION; TRANSSPHENOIDAL SURGERY;

ACROMEGALY; ADENOMA; ADOLESCENT; ADULT; AGED; CHILD; CUSHING SYNDROME; FEMALE; FOLLOW-UP STUDIES; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; NEW ZEALAND; PITUITARY GLAND, ANTERIOR; PITUITARY NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0037678877     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-5994.2003.00348.x     Document Type: Article

References (26)

1. Ahmed S, Elsheikh M, Stratton IM, Page RC, Adams CB, Wass JA. Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrinol 1999; 50: 561-7.
2. Gittoes NJ, Sheppard MC, Johnson AP, Stewart PM. Outcome of surgery for acromegaly - the experience of a dedicated pituitary surgeon. Q J Med 1999; 92: 741-5.
3. Clayton RN. How many surgeons to operate on acromegalic patients? Clin Endocrinol 1999; 50: 557-9.
4. Lissett CA, Peacey SR, Laing I, Tetlow L, Davis J-R, Shalet SM. The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma. Clin Endocrinol 1998; 49: 653-7.
5. Swearingen B, Barker FG II, Katznelson L, Biller BM, Grinspoon S, Klibanski A et al. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 1998; 83: 3419-26.
6. Swearingen B, Biller B, Barker F, Katznelson L, Grinspoon S, Klibanski A et al. Long-term mortality after transsphenoidal surgery for Cushing disease. Ann Intern Med 1999; 130: 821-4.
7. Bochicchio D, Losa M, Buchfelder M. Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group. J Clin Endocrinol Metab 1995; 80: 3114-20.
8. Rasat R, Livesey JL, Espiner EA, Abbott GD, Donald RA. IGF-1 and IGFBP-3 screening for disorders of growth hormone secretion. NZ Med J 1996; 109: 156-9.
9. Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA et al. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's. N Engl J Med 1991; 325: 897-905.
10. Mampalam T, Tyrrell JB, Wilson CB. Transsphenoidal microsurgery for Cushing disease. A report of 216 cases. Ann Intern Med 1988; 109: 487-93.
11. Sonino N, Zielezny M, Fava GA, Fallo F, Boscaro M. Risk factors and long-term outcome in pituitary-dependent Cushing's disease. J Clin Endocrinol Metab 1996; 81: 2647-52.
12. Sheaves R, Jenkins P, Blackburn P, Huneidi AH, Afshar F, Medbak S et al. Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure. Clin Endocrinol 1996; 45: 407-13.
13. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K et al. Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 2000; 85: 526-9.
14. Arnott RD, Pestell RG, McKelvie PA, Henderson JK, McNeill PM, Alford FP. A critical evaluation of transsphenoidal pituitary surgery in the treatment of Cushing's disease: prediction of outcome. Acta Endocrinol 1990; 123: 423-30.
15. Trainer PJ, Lawrie HS, Verhelst J, Howlett TA, Lowe DG, Grossman AB et al. Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol 1993; 38: 73-8.
16. McCance DR, Gordon DS, Fannin TF, Hadden DR, Kennedy L, Sheridan B et al. Assessment of endocrine function after transsphenoidal surgery for Cushing's disease. Clin Endocrinol 1993; 38: 79-86.
17. Toms GC, McCarthy MI, Niven MJ, Orteu CH, King TT, Monson JP. Predicting relapse after transsphenoidal surgery for Cushing's disease. J Clin Endocrinol Metab 1993; 76: 291-4.
18. McCance DR, Besser M, Atkinson AB. Assessment of cure after transsphenoidal surgery for Cushing's disease. Clin Endocrinol 1996; 44: 1-6.
19. Simmons NE, Alden TD, Thorner MO, Laws ER Jr, Serum cortisol response to transsphenoidal surgery for Cushing disease. J Neurosurg 2001; 95: 1-8.
20. Guilhaume B, Bertagna X, Thomsen M, Bricaire C, Vila-Porcile E, Olivier L et al. Transsphenoidal pituitary surgery for the treatment of Cushing's disease: results in 64 patients and long term follow-up studies. J Clin Endocrinol Metab 1988; 66: 1056-64.
21. Bates AS, Van't Hoff W, Jones JM, Clayton RN. An audit of outcome of treatment in acromegaly. Q J Med 1993; 86: 293-9.
22. Etxabe J, Gaztambide S, Latorre P, Vazquez J. Acromegaly: an epidemiological study. J Endocrinol Invest 1993; 16: 181-7.
23. Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK. Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol 1994; 41: 95-102.
24. Orme S, McNally R, Cartwright R, Belchetz P. Mortality and cancer incidence in acromegaly: a retrospective cohort study. J Clin Endocrinol Metab 1998; 83: 2730-4.
25. Plotz C, Knowlton A, Ragan C. The natural history of Cushing's syndrome. Am J Med 1952; 13: 597-614.
26. Etxabe J, Vazquez J. Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol 1994; 40: 479-84.